Juvenile obesity: the pathogenetic aspects and therapeutic outlook
Catassi, C.
Recenti Progressi in Medicina 90(4): 196-201
1999
ISSN/ISBN: 0034-1193 PMID: 10354731 Document Number: 511509
Document emailed within 1 workday
Related Documents
Masek, J. 1970: Various pathogenetic aspects of obesity Bratislavske Lekarske Listy 54(5): 536-543Furrer, H.U. 1978: Diarrhea: pathogenetic and therapeutic aspects Therapeutische Umschau. Revue Therapeutique 35(8): 642-646
Laviano, A.; Cascino, A.; Muscaritoli, M.; Rossi Fanelli, F. 2000: Pathogenetic and therapeutic aspects of secondary anorexia Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 15(3): 199-205
Damulin, I.V. 2009: Pathogenetic and therapeutic aspects of dementia in Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(2): 73-77
Saggese, G.; Baroncelli, G.I.; Bertelloni, S.; Ferrari, M.; Bernini Vanni, P. 1987: Amelogenesis imperfecta. Pathogenetic aspects and therapeutic guidelines Minerva Pediatrica 39(1-2): 9-13
Erdberg, A.; Rosenberg, D. 1987: Pathogenetic and therapeutic aspects of rapidly progressive glomerulonephritis Harefuah 113(1-2): 31-33
Gurevich, M.A. 2003: Pathogenetic and therapeutic aspects of isolated systolic arterial hypertension in the elderly Klinicheskaia Meditsina 81(5): 56-58
Zukowska-Szczechowska, E.; Tomaszewski, M.; Grzeszczak, W. 2001: Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects Przeglad Lekarski 58(3): 124-126
Hopf, U.; Stemerowicz, R.; Knigge, O.; Khadar, R.; König, V.; Lobeck, H.; Neuhaus, P. 1993: Primary sclerosing cholangitis (PSC)--humoral immune phenomena, pathogenetic aspects and therapeutic possibilities Zeitschrift für Gastroenterologie 31(Suppl 2): 106-110
Tereshchenko, I.V. 1993: Pathogenetic rationale for the treatment of obesity Problemy Endokrinologii 39(4): 18-21
Tsutsul'kovskaia, M.I.; Abramova, L.I.; Shakhmatova, I.V.; Shapiro, I.A.; Eliaeva, V.N. 1982: Final stages of juvenile malignant schizophrenia (clinico-pathogenetic correlations) Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 82(7): 117-127
Lumholtz, I.B. 1976: Drug information for nurses. Obesity; therapeutic main group: anorectics, appetite depressants. 3. Complications of obesity Sygeplejersken 76(40): 11
Spanár, E.; Uhrín, P.; Levcík, A.; Záhradný, V. 1977: Pathogenetic relationships between obesity and maturity-onset diabetes Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 32(11): Suppl: 170-171
Grugni, G.; Guzzaloni, G.; Ardizzi, A.; Moro, D.; Morabito, F. 1997: Dexfentluramine in the treatment of juvenile obesity Minerva Pediatrica 49(3): 109-117
Khukhlina, O.S.; Antoniv, A.A.; Mandryk, O.Y.; Hryniuk, O.Y.е; Kovalenko, S.V.; Drozd, V.Y.; Kotsiubiichuk, Z.I. 2018: Clinical and pathogenetic features of nonalcoholic steatohepatitis for comorbidity with bronchial asthma on the background of obesity Wiadomosci Lekarskie 71(2 Part 1): 376-379
Buta, L.; Someşan, I. 1992: Infantile and juvenile obesity: a medicosocial problem Pediatrie 41(2): 66-70
Moskalenko, V.F.; Pishchykov, V.A.; Shapovalova, V.A.; Putsev, A.I. 2000: The status of and developmental outlook for sports medicine and therapeutic physical exercise in Ukraine Likars'ka Sprava 5: 3-10
Guggenheim, K.; Poznanski, R.; Kaufmann, N.A. 1977: Attitudes of adolescents to their body build and the problem of juvenile obesity International Journal of Obesity 1(2): 135-149
Rødahl, E. 1989: Pathogenetic aspects of autoimmunity Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(25): 2548-2550
Saba, V.; Muzzonigro, G.; Mingolla, F.; Aló, F. 1980: Current pathogenetic and therapeutic concepts concerning priapism Minerva Medica 71(3): 231-233